Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations

被引:5
|
作者
Huang, Lien-Hung [1 ,2 ]
Hsieh, Ting-Min [2 ,3 ]
Huang, Chun-Ying [2 ,3 ]
Liu, Yueh-Wei [2 ,4 ]
Wu, Shao-Chun [2 ,5 ]
Chien, Peng-Chen [2 ,3 ]
Hsieh, Ching-Hua [2 ,3 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 88301, Taiwan
[2] Chang Gung Univ, Coll Med, Kaohsiung 88301, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Dept Trauma Surg, Kaohsiung 88301, Taiwan
[4] Kaohsiung Chang Gung Mem Hosp, Dept Gen Surg, Kaohsiung 88301, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 88301, Taiwan
关键词
hepatocellular carcinoma; tumor microenvironment; Asian; non-Asian; ESTIMATE; CIBERSORT; LIVER-CANCER; RISK; EPIDEMIOLOGY; FIBROBLASTS; MECHANISMS;
D O I
10.3390/genes12081274
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hepatocellular carcinoma (HCC) is the most common cause of primary liver cancer deaths worldwide. The major risk factors for liver cancer development are cirrhosis, hepatitis B virus (HBV), hepatitis C virus (HCV) infection, and chronic alcohol abuse. HCC displays heterogeneity in terms of biology, etiology, and epidemiology. In Southeast Asia and Africa, chronic HBV infection is a major risk factor for HCC, whereas chronic HCV infection is a risk factor for HCC in western countries and Japan. Environmental and genetic conditions also play a role in the regional and temporal variations in the incidence of HCC. In this study, we used the ESTIMATE (ESTIMATE, Estimation of stromal and immune cells in malignant tumor tissues using expression data) algorithm and the CIBERSOFT tool to analyze gene expression profiles and infiltrating immune cells in HCC between Asian and non-Asian patients. The results showed that stromal and immune scores were dependent on overall survival (OS) in non-Asian patients but not in Asian patients. Kaplan-Meier survival analysis revealed four differentially expressed genes (DEGs) that were significantly associated with OS in non-Asian patients only. CIBERSORT (CIBERSORT, Cell type identification by estimating relative subsets of known RNA transcripts) analysis indicated that the composition of infiltrating immune cells was significantly different between Asian and non-Asian patients. By parsing the subclasses of HCC, the ability to predict prognosis and guide therapeutic targets for potentially actionable HCC may be improved.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma
    Kong, Lingwang
    Liu, Miao
    Yang, Hang
    Yan, Ping
    Luo, Yunhai
    Xiang, Song
    Huang, Zuotian
    Shen, Ai
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (05) : 2251 - 2265
  • [32] No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
    Sawai, Hiromi
    Nishida, Nao
    Mbarek, Hamdi
    Matsuda, Koichi
    Mawatari, Yoriko
    Yamaoka, Megumi
    Hige, Shuhei
    Kang, Jong-Hon
    Abe, Koichi
    Mochida, Satoshi
    Watanabe, Masaaki
    Kurosaki, Masayuki
    Asahina, Yasuhiro
    Izumi, Namiki
    Honda, Masao
    Kaneko, Shuichi
    Tanaka, Eiji
    Matsuura, Kentaro
    Itoh, Yoshito
    Mita, Eiji
    Korenaga, Masaaki
    Hino, Keisuke
    Murawaki, Yoshikazu
    Hiasa, Yoichi
    Ide, Tatsuya
    Ito, Kiyoaki
    Sugiyama, Masaya
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Park, Jun Yong
    Yuen, Man-Fung
    Nakamura, Yusuke
    Tanaka, Yasuhito
    Mizokami, Masashi
    Tokunaga, Katsushi
    BMC MEDICAL GENETICS, 2012, 13
  • [33] A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma
    Yang, Zhan
    Li, Xinmiao
    Pan, Chaoran
    Li, Yifei
    Lin, Lifan
    Jin, Yan
    Zheng, Jianjian
    Yu, Zhengping
    BMC CANCER, 2022, 22 (01)
  • [34] A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma
    Zhan Yang
    Xinmiao Li
    Chaoran Pan
    Yifei Li
    Lifan Lin
    Yan Jin
    Jianjian Zheng
    Zhengping Yu
    BMC Cancer, 22
  • [35] Prognostic landscape of tumor-infiltrating immune cells and immunerelated genes in the tumor microenvironment of gastric cancer
    Zhang, Shichao
    Zeng, Zhu
    Liu, Yongfen
    Huang, Jiangtao
    Long, Jinhua
    Wang, Yun
    Peng, Xiaoyan
    Hu, Zuquan
    Ouyang, Yan
    AGING-US, 2020, 12 (18): : 17958 - 17975
  • [36] Impact of anesthesia-related genes on prognosis and tumor microenvironment in hepatocellular carcinoma: A comprehensive analysis
    Xu, Xia
    Hu, Lihong
    ENVIRONMENTAL TOXICOLOGY, 2024, : 4700 - 4711
  • [37] Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma
    Du, Bowen
    Zhou, Yulin
    Yi, Xiaoming
    Zhao, Tangliang
    Tang, Chaopeng
    Shen, Tianyi
    Zhou, Kai
    Wei, Huixian
    Xu, Song
    Dong, Jie
    Qu, Le
    He, Haowei
    Zhou, Wenquan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer
    Li, Faping
    Guo, Hui
    Wang, Yishu
    Liu, Bin
    Zhou, Honglan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
  • [39] Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma
    Gao, Weike
    Li, Luan
    Han, Xinyin
    Liu, Siyao
    Li, Chengzhen
    Yu, Guanying
    Zhang, Lei
    Zhang, Dongsheng
    Liu, Caiyun
    Meng, Erhong
    Hong, Shuai
    Wang, Dongliang
    Guo, Peiming
    Shi, Guangjun
    BMC CANCER, 2021, 21 (01)
  • [40] Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma
    Weike Gao
    Luan Li
    Xinyin Han
    Siyao Liu
    Chengzhen Li
    Guanying Yu
    Lei Zhang
    Dongsheng Zhang
    Caiyun Liu
    Erhong Meng
    Shuai Hong
    Dongliang Wang
    Peiming Guo
    Guangjun Shi
    BMC Cancer, 21